Study Evaluating Safety of Ragweed Mix Given by Intralymphatic Node Injections

NCT03038971 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor withdrew IND from FDA

Conditions

Allergic Conjunctivitis
Allergic Rhinitis

Interventions

BIOLOGICAL: Dose Level 1
BIOLOGICAL: Dose Level 2
BIOLOGICAL: Placebo

Sponsor

Woodmont Pharmaceuticals, Inc.

Collaborators

[object Object]